Montané E, Santesmases J (2020) Adverse drug reactions. Med Clin (Barc) 154(5):178–184. https://doi.org/10.1016/j.medcli.2019.08.007

Article  CAS  PubMed  Google Scholar 

Langmia IM, Just KS, Yamoune S et al (2021) CYP2B6 functional variability in drug metabolism and exposure across populations-implication for drug safety, dosing, and individualized therapy. Front Genet 12:692234. https://doi.org/10.3389/fgene.2021.692234

Article  CAS  PubMed  Google Scholar 

Pirmohamed M (2023) Pharmacogenomics: current status and future perspectives. Nat Rev Genet 24(6):350–362. https://doi.org/10.1038/s41576-022-00572-8

Article  CAS  PubMed  Google Scholar 

Zhang H, De T, Zhong Y et al (2019) The advantages and challenges of diversity in pharmacogenomics: can minority populations bring us closer to implementation? Clin Pharmacol Ther 106(2):338–349. https://doi.org/10.1002/cpt.1491

Article  PubMed  Google Scholar 

Danese E, Raimondi S, Montagnana M et al (2019) Effect of CYP4F2, VKORC1, and CYP2C9 in influencing coumarin dose: a single-patient data meta-analysis in more than 15,000 individuals. Clin Pharmacol Ther 105(6):1477–1491. https://doi.org/10.1002/cpt.1323

Article  CAS  PubMed  Google Scholar 

Johnson JA, Caudle KE, Gong L et al (2017) Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics-guided warfarin dosing: 2017 update. Clin Pharmacol Ther 102(3):397–404. https://doi.org/10.1002/cpt.668

Article  CAS  PubMed  Google Scholar 

Sitabule BR, Othman H, Choudhury A et al (2023) Promoting pharmacogenomics in Africa: perspectives from variation in G6PD and other pharmacogenes. Clin Pharmacol Ther 113(3):476–479. https://doi.org/10.1002/cpt.2816

Article  PubMed  Google Scholar 

Haas DW, Abdelwahab MT, van Beek SW et al (2022) Pharmacogenetics of between-individual variability in plasma clearance of bedaquiline and clofazimine in South Africa. J Infect Dis 226(1):147–156. https://doi.org/10.1093/infdis/jiac024

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li D, Peng L, Xing S et al (2021) Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China. BMC Genom Data. 22(1):51. https://doi.org/10.1186/s12863-021-00999-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng Y, Dai R, Chen W et al (2020) Genetic polymorphisms of pharmacogenomic VIP variants in the Dai population from Yunnan province. Mol Genet Genomic Med 8(7):e1231. https://doi.org/10.1002/mgg3.1231

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang C, Guo W, Cheng Y et al (2019) Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China. Mol Genet Genomic Med 7(5):e574. https://doi.org/10.1002/mgg3.574

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen W, Ding H, Cheng Y et al (2019) Genetic polymorphisms analysis of pharmacogenomic VIP variants in Bai ethnic group from China. Mol Genet Genomic Med 7(9):e884. https://doi.org/10.1002/mgg3.884

Article  PubMed  PubMed Central  Google Scholar 

Dong W, Wang D, Li Y et al (2020) Genetic polymorphism of HPA1–17 alloantigen system in the Achang and Jingpo populations population in Yunnan. Ann Palliat Med. 9(4):1990–1996. https://doi.org/10.21037/apm-20-1075

Article  PubMed  Google Scholar 

Kang H (2021) Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof. 18:17. https://doi.org/10.3352/jeehp.2021.18.17

Article  PubMed  PubMed Central  Google Scholar 

Chamboko CR, Veldman W, Tata RB et al (2023) Human Cytochrome P450 1, 2, 3 families as pharmacogenes with emphases on their antimalarial and antituberculosis drugs and prevalent African alleles. Int J Mol Sci. https://doi.org/10.3390/ijms24043383

Article  PubMed  Google Scholar 

Zhao J, Lin L, Hadiatullah H et al (2023) Characterization of six diamide insecticides on ryanodine receptor: resistance and species selectivity. J Agric Food Chem 71(29):11001–11007. https://doi.org/10.1021/acs.jafc.3c01750

Article  CAS  PubMed  Google Scholar 

Martínez-Iglesias O, Naidoo V, Carrera I et al (2023) Influence of metabolic, transporter, and pathogenic genes on pharmacogenetics and DNA methylation in neurological disorders. Biology (Basel). https://doi.org/10.3390/biology12091156

Article  PubMed  Google Scholar 

Principi N, Petropulacos K, Esposito S (2023) Impact of pharmacogenomics in clinical practice. Pharmaceuticals (Basel). https://doi.org/10.3390/ph16111596

Article  PubMed  Google Scholar 

Arbitrio M, Scionti F, Di Martino MT et al (2021) Pharmacogenomics biomarker discovery and validation for translation in clinical practice. Clin Transl Sci 14(1):113–119. https://doi.org/10.1111/cts.12869

Article  PubMed  Google Scholar 

Kim TH, Chang HS, Park SM et al (2008) Association of angiotensin I-converting enzyme gene polymorphisms with aspirin intolerance in asthmatics. Clin Exp Allergy 38(11):1727–1737. https://doi.org/10.1111/j.1365-2222.2008.03082.x

Article  CAS  PubMed  Google Scholar 

Irvin MR, Lynch AI, Kabagambe EK et al (2010) Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study. J Hypertens 28(10):2076–2083. https://doi.org/10.1097/HJH.0b013e32833c7a4d

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferreira de Oliveira F, Berretta JM, Suchi Chen E et al (2016) Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease. Colomb Med (CA). 47(2):76–80

Article  PubMed Central  Google Scholar 

Vogel LK, Sæbø M, Høyer H et al (2014) Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis. PLoS ONE 9(8):e105254. https://doi.org/10.1371/journal.pone.0105254

Article  PubMed  PubMed Central  Google Scholar 

Yang J, Chen X, Zhou J et al (2018) Associations of candidate gene polymorphisms with poor responsiveness to aspirin: a meta-analysis. Clin Exp Pharmacol Physiol. https://doi.org/10.1111/1440-1681.12973

Article  PubMed  PubMed Central  Google Scholar 

Sharma V, Kaul S, Al-Hazzani A et al (2013) Association of COX-2 rs20417 with aspirin resistance. J Thromb Thrombolysis 35(1):95–99. https://doi.org/10.1007/s11239-012-0777-8

Article  CAS  PubMed  Google Scholar 

Nagao M, Sato Y, Yamauchi A (2013) A meta-analysis of PTGS1 and PTGS2 polymorphisms and NSAID intake on the risk of developing cancer. PLoS ONE 8(8):e71126. https://doi.org/10.1371/journal.pone.0071126

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tiis RP, Osipova LP, Lichman DV et al (2020) Studying polymorphic variants of the NAT2 gene (NAT2*5 and NAT2*7) in Nenets populations of Northern Siberia. BMC Genet 21(Suppl 1):115. https://doi.org/10.1186/s12863-020-00909-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sim E, Walters K, Boukouvala S (2008) Arylamine N-acetyltransferases: from structure to function. Drug Metab Rev 40(3):479–510. https://doi.org/10.1080/03602530802186603

Article  CAS  PubMed  Google Scholar 

Ruiz JD, Martínez C, Anderson K et al (2012) The differential effect of NAT2 variant alleles permits refinement in phenotype inference and identifies a very slow acetylation genotype. PLoS ONE 7(9):e44629. https://doi.org/10.1371/journal.pone.0044629

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adole PS, Kharbanda PS, Sharma S (2016) N-acetyltransferase 2 (NAT2) gene polymorphism as a predisposing factor for phenytoin intoxication in tuberculous meningitis or tuberculoma patients having seizures—a pilot study. Indian J Med Res 143(5):581–590. https://doi.org/10.4103/0971-5916.187106

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gupta VH, Amarapurkar DN, Singh M et al (2013) Association of N-acetyltransferase 2 and cytochrome P450 2E1 gene polymorphisms with antituberculosis drug-induced hepatotoxicity in Western India. J Gastroenterol Hepatol 28(8):1368–1374. https://doi.org/10.1111/jgh.12194

Article  CAS  PubMed  Google Scholar 

Xiang Y, Ma L, Wu W et al (2014) The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1. PLoS ONE 9(1):e85905. https://doi.org/10.1371/journal.pone.0085905

Article  CAS  PubMed  Google Scholar 

Lawi ZK, Al-Shuhaib MBS, Amara IB (2023) The rs1801280 SNP is associated with non-small cell lung carcinoma by exhibiting a highly deleterious effect on N-acetyltransferase 2. J Cancer Res Clin Oncol 149(1):147–157. https://doi.org/10.1007/s00432-022-04332-3

Article  CAS  PubMed